Next Article in Journal
Effect of Different Surface Treatments on Titanium Dental Implant Micro-Morphology
Previous Article in Journal
Seebeck and Figure of Merit Enhancement by Rare Earth Doping in Yb14-xRExZnSb11 (x = 0.5)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Osteoclastogenesis Behavior of Zirconia for Dental Implant

1
Department of Prosthodontics and Dental Research Institute, School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
2
Department of Prosthodontics and Dental Research Institute, Seoul National University Dental Hospital, School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
3
Department of Cell and Developmental Biology, School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
4
Department of Dental Regenerative Biotechnology, School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
*
Author to whom correspondence should be addressed.
Materials 2019, 12(5), 732; https://doi.org/10.3390/ma12050732
Submission received: 28 January 2019 / Revised: 20 February 2019 / Accepted: 26 February 2019 / Published: 4 March 2019

Abstract

:
Zirconia is worth studying as an alternative to dental titanium implants to overcome the disadvantages of titanium. This study investigated the surface characteristics of the zirconia implant material and osteoclastogenesis responses on the surface compared with titanium. Yttrium oxide-stabilized 5% tetragonal zirconia polycrystalline specimens were manufactured, and osteoclast-precursor cells were cultured and differentiated into osteoclasts on the specimens. Surface shape, roughness, and chemical composition were evaluated. After culturing, cell morphologies and differentiation capacity were analyzed using tartrate-resistant acid phosphatase activity (TRACP). mRNA of two critical transcription factors, nuclear factor of activated T-cells 1 (NFATc1) and c-Fos were measured, and protein levels of NFATc1 and c-Fos were investigated. The zirconia specimens had rhomboid-like shapes with smooth surfaces and exhibited no difference in surface roughness compared to the titanium specimens. Morphologies of differentiated osteoclasts on both materials were similar. TRACP activity on the zirconia showed comparable results to that on the titanium. The mRNA value of NFATc1 on the zirconia was higher than that on the titanium at day four. The protein level of c-Fos was expressed thicker on the zirconia when compared to the titanium at day two. The results of this study suggest that zirconia material provides adequate osteoclastogenesis behaviors for dental implant use.

1. Introduction

Titanium (Ti) has been studied for years not only for dental implants but also for medical fields including orthopedic implants because of its great biocompatibility and high bone-tissue affinity [1,2,3]. In addition, modification of Ti material itself and Ti surface treatment have been experimented to obtain better properties [4,5,6,7,8]. Bernardi et al. [4] investigated the antibacterial properties of anatase-coated titanium healing screws and revealed that the coated screw preserved implant-surrounding tissues from micro-organism. Until now, Ti-based alloys are the most widely used as dental implant materials and exhibit good mechanical characteristics and long-term clinical success [9,10]. However, there are disadvantages to using Ti in dental applications. Clinicians have been forced to study hypersensitivity and allergic reactions in patients with dental implants due to unexplained implant failures [11]. Twenty-one of the 56 people who had received Ti implant showed a sensitive reaction to Ti through lymphocyte transformation tests [12]. An in vitro study investigated soft tissue discoloration placing Ti and ceramic materials under grafted mucosa [13], and Ti induced the most prominent discoloration in the mucosa.
The negative effects of Ti have driven many researchers to investigate the potential of ceramic implants for use in dental applications. Plecko et al. [14] compared four different metallic implant materials for their osseointegration and biocompatibility, and reported that zirconium and/or titanium based coatings improved osseointegration of cobalt–chrome and showed osseointegration similar to pure titanium [14]. Ceramic materials have been utilized in dental fields for long periods [15]. To overcome the drawbacks of Ti implants, ceramic material has been focus of research. Zirconium oxide, such as alumina-toughened zirconia and zirconia-toughened alumina, showed potential as an alternative to yttrium oxide-stabilized tetragonal zirconia polycrystals [15]. Strong ceramics exhibited bio-inert properties similar to stainless steel and showed a lower release of ions compared to metals [16]. Osseointegration between bone and ceramic material has been observed without inflammation, further supporting the potential use of ceramics in dental implants [17]. As a ceramic implant material, zirconia is composed of yttrium oxide (Y2O3)-stabilized 5% tetragonal zirconia polycrystals (Y-TZP) and is used in dental restorations [18]. Zirconia implants have the potential to replace Ti implants for short-term clinical use because both materials cause a similar hard tissue response [19,20]. Zirconia implants decreased bacterial adhesion compared to that of Ti implants, reducing the potential for inflammation around the implants [21]. Osteoblasts, a primary cell critical for bone growth and osseointegration, were able to attach to zirconia surfaces [22].
In perspective of bone physiology, cooperative interactions occur between osteoblasts and osteoclasts, which contribute to bone formation and resorption. And both cells are required for bone remodeling after implant insertion [23]. Bone necrosis of the jaw called antiresorptive agent-related osteonecrosis of the jaw could occur when a patient with osteoporosis uses an antiresorptive agent, a bisphosphonate which inhibits osteoclast activity of resorption [24,25,26]. This phenomenon indicates the balance between osteoblast and osteoclast is essential in bone metabolism [25,26]. Many researches on osseointegration of implant surfaces have focused on bone-forming osteoblasts. Much less is known regarding the function of osteoclasts in osseointegration. Osteoclasts are critical for bone resorption and have roles in early and late tissue responses after implant insertion [27].
We hypothesized that zirconia would be an acceptable material for osteoclast differentiation and have conducted experimental osteoclastogenesis on the surface of zirconia and Ti. The current study investigated the characteristics of zirconia compared to Ti surfaces assessing visual and quantitative properties of osteoclasts on zirconia and Ti disks. Two indicating factors for differentiation of osteoclasts in mRNA and protein level were examined to analyze gene expression.

2. Materials and Methods

2.1. Zirconia and Titanium Specimen Preparation and Analyses of Surface Characteristics

As the experimental group, thirty zirconia disks were fabricated via cold isostatic pressing at 200 MPa then sintered for 2 h at 1650 °C in air. Zirconia specimens were composed of yttria-stabilized tetragonal zirconia polycrystals (94.5 mol% ZrO2, 5.1 mol% Y2O2, 0.25 mol% Al2O3) (Ecucera, Pocheon, South Korea). Each disk had uniform dimensions with a 15-mm diameter and 1-mm thickness. Thirty machine-surfaced Ti disks (15 mm in diameter and 1 mm in thickness) were manufactured from commercially pure Ti grade IV (Warantec, Seoul, South Korea) as a control. All disks were washed in distilled water and ultrasonically cleaned with alcohol. Disks were then dried and autoclaved at 120 °C for 30 min. The disks surfaces were coated with a platinum film and viewed with a field emission scanning electron microscope (FE-SEM) (S-4700; Hitachi, Tokyo, Japan) using an acceleration voltage of 15 kV at three magnifications (×1000; ×5000; ×20,000). 3D images and surface roughness were obtained by confocal laser scanning microscopy (CLSM) (LSM 5; Pascal, Zeiss, Obercochen, Germany). Energy dispersive X-ray spectroscopy (EDS) (EX-250; Horiba, Tokyo, Japan) was conducted to assess the chemical composition of the disks. Each evaluation was conducted with three disks for each group.

2.2. Analyses of Osteoclastogenesis on Zirconia and Titanium Specimens

2.2.1. Raw Cell Preparation and Osteoclast Differentiation Processing

Murine RAW264.7 macrophage/monocyte cells (TIB-71; American Type Culture Collection, Rockville, MD, USA) were cultured on the surfaces of zirconia and Ti disks [28]. Disks were placed at the bottom of a 12-well plate at 37 °C in a humidified atmosphere of 5% CO2 in Minimum Essential Medium Alpha (α–MEM; Gibco, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; Gibco, Rockville, MD, USA), 100 U/mL penicillin, and 100 µg/mL streptomycin. The cells were suspended in 250 µL α–MEM, and were directly seeded on top of the disk surface at a density of 2 × 104 cells/disk, not on the residual space of the well. After adhering cells to the disk for 6 h, the medium was changed to cover the entire well [28]. One hundred nanograms/milliliter of mouse Receptor activator of nuclear factor Kappa-B ligand (RANKL, Peprotech, Rocky Hill, NJ, USA) was added to induce osteoclast differentiation. RANKL and medium were changed every two days.

2.2.2. Osteoclast Cell Morphologic Analysis by FE-SEM

After three days of culture on the disks, cells were fixed with 2% glutaraldehyde in phosphate buffered saline (PBS) for 10 min at room temperature [28]. Cells were stained with 2% osmium tetroxide in PBS for 15 min and dehydrated in an ascending ethanol series. After critical point drying, samples were sputter-coated with 6 nm platinum and then examined in the FE-SEM. Observations were performed at three different areas on 4 disks for each group.

2.2.3. Tartrate-Resistant Acid Phosphatase Activity Assay

Tartrate-resistant acid phosphatase (TRACP) enzyme activity was measured to quantitatively evaluate osteoclast differentiation activity. Cells were treated with RANKL for three and five days, and TRACP activity was measured using the TRACP assay kit (Takara, Kyoto, Japan) according to the manufacturer’s protocol. The TRACP activities of the cultured cells were examined by a colorimetric assay utilizing the conversion of colorless p-nitrophenol phosphate to colored p-nitrophenol. The concentration of p-nitrophenol was measured spectrophotometrically by taking sample absorbance readings at 405 nm (Bio-Rad, Hercules, CA, USA). Replicate measurements were performed with 4 disks for each group.

2.2.4. Osteoclast Gene Analysis by mRNA Expression Assessment

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was conducted to investigate mRNA levels in osteoclast cells for one reference gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and two target genes, nuclear factor of activated T-cells 1 (NFATc1) and c-Fos. Total ribonucleic acid (RNA) was isolated from cell samples after two and four days of treatment with RANKL. Cells were lysed by adding the TRIzol® reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. The homogenized samples were incubated for 5 min at room temperature to permit the complete dissociation of nucleoprotein complexes. Then, 0.2 mL of chloroform was added to each sample, and the samples were mixed vigorously and then incubated at room temperature for 3 min. The samples were centrifuged at 12,000× g for 15 min at 4 °C. Following centrifugation, the mixture was separated into a lower red, phenol-chloroform phase, an interphase, and a colorless upper aqueous phase. RNA was precipitated from the aqueous phase by mixing with 0.4 mL of isopropyl alcohol. The samples were incubated at room temperature for 10 min and centrifuged for 10 min at 4 °C. The RNA precipitate formed a gel-like pellet on the side and bottom of the tube. After removing the supernatant, the RNA pellet was washed with 1 mL of 75% ethanol and centrifuged at 12,000× g for 5 min at 4 °C. The RNA pellet was dried for 5 min. RNA was dissolved in RNase-free water and incubated at 55 °C for 10 min. Total RNA was quantified using a Nanodrop Spectrophotometer (ThermoScientific Nanodrop Technologies, Wilmington, DE, USA); 1 μg of total RNA was reverse transcribed to cDNA at 42 °C for 50 min using the Superscript II (SSII) reverse transcriptase (Invitrogen) that contains oligo (dT), 2.5 mM dNTP, 5xFS buffer, 0.1M DTT, SSII enzyme, and RNase out.
Real-time PCR was performed in an iCycler (Bio-Rad) using SYBR green (Invitrogen) detection. Each reaction contained 5 μL of cDNA, 0.4 μL of the forward and reverse specific primers (Table 1), and 0.4 μL of rhodamine X (ROX) in a final volume of 20 μL. The amplification program consisted of a pre-incubation step for denaturation of the template cDNA (3 min 95 °C), followed by 40 cycles consisting of a denaturation step (15 s for 95 °C), an annealing step (15 s for 60 °C), and an extension step (30 s for 72 °C). Samples were run in triplicate (n = 12). Levels of c-Fos and NFAcT1 were normalized to GAPDH.

2.2.5. Osteoclast Gene Analysis by Protein Expression Assessment

The protein expression levels of 2 genes, c-Fos, and NFATc1, were assessed via Western blot analysis [29]. RAW264.7 cells were grown on Ti and zirconia disks for one, two, and three days after treatment of RANKL. After washing with PBS, total cell lysates were harvested by lysing the cells with chilled radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris pH 7.2, 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid, 1 mM NaF, 2.5 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 1 μg/mL leupeptin, 1 µg/mL aprotinin, 1% Triton X-100, 0.1% SDS and 1% deoxycholate). Total cell lysates were incubated for 20 min and centrifuged at 14,000× g for 15 min at 4 °C. Harvested proteins were separated by 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane (Whatman GmbH, Dassel, Germany). The membrane was probed with specific antibodies (Santa Cruz Biotechnology, Heidelberg, Germany) with a concentration of 2 μg/mL and the reactivity of the immune complexes were detected by using enhanced chemiluminescence (ECL, GE Healthcare, Hatfield, Hertfordshire, UK) reagents.

2.3. Statistical Analysis

Statistical significance for all data comparisons was determined by student t-test analysis (SPSS 23, IBM Inc., Armonk, NY, USA). p-values less than 0.05 were considered statistically significant.

3. Results

3.1. Surface Characteristics of the Zirconia and the Titanium Specimens

In SEM views, the zirconia specimens had rhomboid-like shapes with smooth surfaces, and the Ti specimens exhibited a flat surface with striped patterns. (Figure 1).
3D image of the microstructures on the surface of each disk is shown in Figure 2. Results for the surface roughness-related parameters for each disk are summarized in Figure 3. The Ra (surface roughness) and Sa (arithmetic mean height deviation from a mean plane) values for Ti disks were 0.59 ± 0.07 µm and 0.59 ± 0.02 µm, respectively. The Ra and Sa values for zirconia disks were 0.66 ± 0.22 µm and 0.71 ± 0.21 µm, respectively. There was no statistically significant difference between the overall roughness of Ti and zirconia surfaces.
EDS spectra revealed Zi peaks for zirconia disks and Ti peaks for Ti disks, confirming that both disks were pure and free from any contamination for further cell experiments (Figure 4).

3.2. FE-SEM Assessment of Cell Morphology

Differentiated osteoclasts morphologies are shown in Figure 5. Osteoclasts were spread regularly on the surfaces of both Ti and zirconia disks. A high magnification FE-SEM image (×2000) confirmed that cells grown on both surfaces displayed morphologies characteristic of well-differentiated osteoclasts. Osteoclasts on both Ti and zirconia disks showed similar morphologies that had irregular shapes with ruffled borders stretching out from its body, attached to the surface (Figure 5b,d).

3.3. Tartrate-Resistant Acid Phosphatase Activity

At day three, absorbance value was 0.301 ± 0.016 for Ti and 0.286 ± 0.024 for zirconia disks (Figure 6a). At day five, absorbance value was 0.461 ± 0.043 for Ti and 0.461 ± 0.026 for zirconia disks (Figure 6b). There were no significant differences between the TRACP activities of cells grown on zirconia and Ti disks at either three or five days.
3.4. mRNA Expression of c-Fos and NFATc1
mRNA levels assessed by RT-PCR on RNA harvested from cells that were treated with RANKL for two and four days are shown in Figure 7. All mRNA levels were normalized to values collected for Ti disks on day two. At day two, the relative expression of c-Fos mRNA was 1.205 ± 0.278 for zirconia and 0.921 ± 0.093 for Ti. At day four, the relative expression of c-Fos was 2.124 ± 0.474 for zirconia and 1.514 ± 0.124 for Ti. These results did not show any significant differences (Figure 7a). At day two, the relative expression of NFATc1 mRNA was 0.913 ± 0.036 for zirconia and 0.911 ± 0.106 for Ti, which showed no significant difference. However, at day four, relative expression of NFATc1 mRNA levels on zirconia (2.831 ± 0.492) was significantly higher than that on Ti (1.722 ± 0.158) (p = 0.02) (Figure 7b).

3.5. Protein Expression of c-Fos and NFATc1

Figure 8 shows protein expressions with western blot analysis for c-Fos and NFATc1. We observed that c-Fos protein levels were slightly thicker for zirconia disks when compared to Ti disks at day two whereas protein levels on zirconia and Ti disks were similar at day three. Protein levels of NFATc1 were similar across all treatment groups.

4. Discussion

Osseointegration describes the structural and functional complex that occurs between an implant surface and the inner bone [30] which is critical for the survival of an implant after insertion into the body. For many decades, Ti has been used as a material for dental implants. However, the disadvantages of Ti as implant material have pushed dental clinicians to study other materials that could replace Ti. In the biomaterials field, ceramic materials are gaining popularity due to their increased strength, enhanced fracture resistance, durability, and excellent biocompatibility [31]. Zirconia is a polymorphic material that appears in three forms: monoclinic, cubic, and tetragonal and which is a novel material for application in dental ceramics [32]. This material has a high potential for use in dental implants due to its tooth-like color, its good mechanical properties, and its excellent biocompatibility [33]. It is possible that zirconia could be used as a non-metal implant and replace the use of titanium [34].
The present study may be the first study to compare osteoclast cell responses on zirconia and Ti materials directly. Given that osteoclast differentiation is likely to play an important role in peri-implant bone remodeling [35] we selected osteoclast cells as an experimental model, and evaluated diverse responses of osteoclasts on the zirconia surface. Mature osteoclasts can be induced to resorb bone upon stimulation with RANKL and macrophage-colony stimulating factor (M-CSF) [36]. Murine bone marrow macrophage cell line, RAW264.7 cells were used as osteoclast precursor cells. In this study, cells in 250 µL media were directly seeded on top of the disk surface with caution, not on the residual space of the well. Cells were incubated for 6 h to attach to the disk, and then the medium was changed to cover the entire well. Even though time was given for those to be attached on the disk, cells might possibly move to residual space of the well when they grew. If most cells grew on the disk, but some of the cells grew in the remaining space outside the disk, it might affect the results of this study. Nevertheless, since all the specimens were of the same size, there appears to be of value as a comparative study of the two materials.
To induce osteoclast differentiation, we allowed them to proliferate for 6 h and then treated them with RANKL. The effects of zirconia surface itself on osteoclast cellular responses were compared with those on Ti surface. In this study, a surface roughness of the zirconia disk did not show any difference with that of the Ti disk. Considering that the surface topography of materials contributed to differences in osteoclast behavior in previous reports [37,38,39], the surface roughness did not affect cellular responses in a comparison between the zirconia and Ti surfaces. We also showed that zirconia and Ti disks were pure and contained no contaminants using EDS.
Potent TRACP activity is found in osteoclasts and is a suitable biochemical probe for osteoclast function [40,41]. TRACP is a lysosomal acid phosphatase that osteoclasts secrete to perform their specialized resorption process. TRACP activities of osteoclasts on Ti and zirconia disks for three and five days did not show any significant difference. Secreting similar amount of TRACP enzymes on both zirconia and Ti disks indicated that the quantities of differentiated cells on both disks were similar amounts. Moreover, FE-SEM displayed the same morphologies of osteoclasts on both Ti and zirconia disks. From quantitative and visual aspects, osteoclast behaviors on both disks were proven to be comparable to each other.
c-Fos and NFATc1 are known as major transcription factors required for the osteoclast differentiation of terminal stage and are strongly induced by RANKL stimulation [42]. Western blot analysis was conducted to measure protein levels of NFATc1 and c-Fos. Protein levels were assessed at one, two and, three days after treatment with RANKL. At day two, cells grown on zirconia showed higher levels of c-Fos protein relative to those grown on Ti. However, on day three, the abundance of c-Fos protein on both disks did not vary each other. Even though c-Fos is an important indicating factor for osteoclastogenesis, NFATc1 could induce osteoclast differentiation in the absence of c-Fos [43]. In other words, as long as the protein levels of NFATc1 are similar on both disks, it could induce comparable osteoclast differentiation even when there is no c-Fos protein. In the case of NFATc1, there were no significant differences in protein levels between cells grown on zirconia and Ti disks for any experimental time point. These observations indicate that zirconia induces similar osteoclast cell responses relative to Ti.
We conducted real-time RT-PCR to assess mRNA level of NFATc1 and c-fos after treatment with RANKL for two and four days. At day two, there were no differences in mRNA levels of either transcription factors for cells grown on either Ti or zirconia disks. There was not a significant difference in c-Fos mRNA level between zirconia and Ti disks at day four. mRNA level of NFATc1 of zirconia for day four was significantly higher than that of Ti. Annette et al. [44] reported poor correlations between mRNA transcript levels and the protein produced. Protein is the final product of transcription that proceeds direct modulation of osteoclastgenesis. This implies that variation in mRNA level may have little impact compared to the respective protein [44]. Taken together, the results of this study indicate that both disks displayed identical surface responses toward osteoclast behaviors.
Nonmetallic materials with high mechanical properties are required [15]. Low elasticity and mechanical property are the disadvantages of the zirconia implant [45,46]. There have been attempts to overcome its disadvantage, using polyetheretherketone restoration with zirconia implant [45], and manufacturing hybrid-type zirconia composing Ti [46]. Even with the current strength, zirconia implants may be appropriate for restoring anterior teeth to achieve aesthetic effects. However, when modification of the abutment angle is required, zirconia implants are difficult to use due to the one-piece manufacturing [15]. Additional research is needed to enable the fabrication of non-metallic implants with biomaterials, such as zirconia, through a digital workflow that enables custom-made, maneuverable, and well-adapted implants. As shown in the results, zirconia, featured similar osteoclast cell behaviors to Ti, and zirconia showed potential properties as a reliable implant material in terms of bioengineering perspectives. In the future, studies focusing not only on osteoclast behaviors but also on interactions with osteoblasts are helpful, and long-term in vivo studies regarding the direct effects of zirconia implants on osseointegration in comparison with Ti implants are needed before a robust recommendation of zirconia for the dental implant material.

5. Conclusions

This study investigated surface characteristics of zirconia implants and osteoclast behaviors in gene level on the surface. Visual evaluation of differentiated osteoclasts confirmed that osteoclastogenesis for both zirconia and Ti implant disks were comparable. Given that two transcriptional factors appearing similarly on both disks, it is possible that zirconia implants could function like Ti implants and induce favorable osseointegration.

Author Contributions

Conceptualization, S.-K.K.; Methodology, S.-K.K., Z.H.L. and J.C.; Software, S.-J.H. and J.-Y.K.; Validation, S.-K.K. and J.C.; Formal Analysis, B.G. and Z.H.L.; Investigation, B.G.; Resources, S.-K.K.; Data Curation, B.G., Z.H.L. and J.C.; Writing—Original Draft Preparation, B.G. and S.-K.K.; Writing—Review and Editing, S.-J.H., J.-Y.K., Z.H.L. and J.C.; Visualization, B.G. and S.-K.K.; Supervision, S.-K.K. All authors gave final approval and agreed to be accountable for all aspects of the work.

Funding

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A1B07042333) and by a grant (no. 04-2018-0094) from the SNUDH Research Fund.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Albrektsson, T.; Zarb, G.; Worthington, P.; Eriksson, A.R. The long-term efficacy of currently used dental implants. A review and proposed criteria of success. Int. J. Oral Maxillofac. Implant. 1986, 1, 11–25. [Google Scholar]
  2. Smith, D.C. Dental implants: Materials and design considerations. Int. J. Prosthodont. 1993, 6, 106–117. [Google Scholar] [PubMed]
  3. Guillaume, B. Dental implants: A review. Morphologie 2016, 100, 189–198. [Google Scholar] [CrossRef] [PubMed]
  4. Bernardi, S.; Bianchi, S.; Botticelli, G.; Rastelli, E.; Tomei, A.R.; Palmerini, M.G.; Continenza, M.A.; Macchiarelli, G. Scanning electron microscopy and microbiological approaches for the evaluation of salivary microorganisms behaviour on anatase titanium surfaces: In vitro study. Morphologie 2018, 102, 1–6. [Google Scholar] [CrossRef] [PubMed]
  5. Lee, J.E.; Heo, S.J.; Koak, J.Y.; Kim, S.K.; Han, C.H.; Lee, S.J. Healing response of cortical and cancellous bone around titanium implants. Int. J. Oral Maxillofac. Implant. 2009, 24, 655–662. [Google Scholar]
  6. Cho, Y.J.; Heo, S.J.; Koak, J.Y.; Kim, S.K.; Lee, S.J.; Lee, J.H. Promotion of osseointegration of anodized titanium implants with a 1α,25-dihydroxyvitamin D3 submicron particle coating. Int. J. Oral Maxillofac. Implant. 2011, 26, 1225–1232. [Google Scholar]
  7. Yoo, S.Y.; Kim, S.K.; Heo, S.J.; Koak, J.Y.; Lee, J.H.; Heo, J.M. Biochemical responses of anodized titanium implants with a poly(lactide-co-glycolide)/bone morphogenetic protein-2 submicron particle coating. Part 2: An in vivo study. Int. J. Oral Maxillofac. Implant. 2015, 30, 754–760. [Google Scholar] [CrossRef] [PubMed]
  8. Yoo, S.Y.; Kim, S.K.; Heo, S.J.; Koak, J.Y.; Lee, J.H.; Park, J.M. Biochemical responses of anodized titanium implants with a poly(lactide-co-glycolide)/bone morphogenic protein-2 submicron particle coating. Part 1: An in vitro study. Int. J. Oral Maxillofac. Implant. 2015, 30, 512–518. [Google Scholar] [CrossRef]
  9. Branemark, P.I.; Adell, R.; Breine, U.; Hansson, B.O.; Lindstrom, J.; Ohlsson, A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand. J. Plast. Reconstr. Surg. 1969, 3, 81–100. [Google Scholar] [CrossRef] [PubMed]
  10. Steinemann, S.G. Titanium—The material of choice? Periodontol. 2000 1998, 17, 7–21. [Google Scholar] [CrossRef] [PubMed]
  11. Bilhan, H.; Bural, C.; Geckili, O. Titanium hypersensitivity. A hidden threat for dental implant patients? N. Y. State Dent. J. 2013, 79, 38–43. [Google Scholar] [PubMed]
  12. Muller, K.; Valentine-Thon, E. Hypersensitivity to titanium: Clinical and laboratory evidence. Neuroendocrinol. Endocrinol. Lett. 2006, 27 (Suppl. 1), 31–35. [Google Scholar]
  13. Jung, R.E.; Sailer, I.; Hammerle, C.H.; Attin, T.; Schmidlin, P. In vitro color changes of soft tissues caused by restorative materials. Int. J. Periodontics Restor. Dent. 2007, 27, 251–257. [Google Scholar]
  14. Plecko, M.; Sievert, C.; Andermatt, D.; Frigg, R.; Kronen, P.; Klein, K.; Stubinger, S.; Nuss, K.; Burki, A.; Ferguson, S.; et al. Osseointegration and biocompatibility of different metal implants—A comparative experimental investigation in sheep. BMC Musculoskelet. Disord. 2012, 13, 32. [Google Scholar] [CrossRef] [PubMed]
  15. Mussano, F.; Genova, T.; Munaron, L.; Faga, M.G.; Carossa, S. Ceramic biomaterials for dental implants: Current use and future perspectives. In Dental Implantology and Biomaterial, 2nd ed.; Almasri, M.A., Ed.; Intech: London, UK, 2016; pp. 63–90. [Google Scholar] [CrossRef]
  16. Hayashi, K.; Inadome, T.; Tsumura, H.; Mashima, T.; Sugioka, Y. Bone-implant interface mechanics of in vivo bio-inert ceramics. Biomaterials 1993, 14, 1173–1179. [Google Scholar] [CrossRef]
  17. Scarano, A.; Di Carlo, F.; Quaranta, M.; Piattelli, A. Bone response to zirconia ceramic implants: An experimental study in rabbits. J. Oral Implantol. 2003, 29, 8–12. [Google Scholar] [CrossRef]
  18. Manicone, P.F.; Rossi Iommetti, P.; Raffaelli, L. An overview of zirconia ceramics: Basic properties and clinical applications. J. Dent. 2007, 35, 819–826. [Google Scholar] [CrossRef] [PubMed]
  19. Depprich, R.; Zipprich, H.; Ommerborn, M.; Mahn, E.; Lammers, L.; Handschel, J.; Naujoks, C.; Wiesmann, H.P.; Kubler, N.R.; Meyer, U. Osseointegration of zirconia implants: An SEM observation of the bone-implant interface. Head Face Med. 2008, 4, 25. [Google Scholar] [CrossRef] [PubMed]
  20. Wenz, H.J.; Bartsch, J.; Wolfart, S.; Kern, M. Osseointegration and clinical success of zirconia dental implants: A systematic review. Int. J. Prosthodont. 2008, 21, 27–36. [Google Scholar] [PubMed]
  21. Scarano, A.; Piattelli, M.; Caputi, S.; Favero, G.A.; Piattelli, A. Bacterial adhesion on commercially pure titanium and zirconium oxide disks: An in vivo human study. J. Periodontol. 2004, 75, 292–296. [Google Scholar] [CrossRef] [PubMed]
  22. Depprich, R.; Ommerborn, M.; Zipprich, H.; Naujoks, C.; Handschel, J.; Wiesmann, H.P.; Kubler, N.R.; Meyer, U. Behavior of osteoblastic cells cultured on titanium and structured zirconia surfaces. Head Face Med. 2008, 4, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Suda, T.; Udagawa, N.; Nakamura, I.; Miyaura, C.; Takahashi, N. Modulation of osteoclast differentiation by local factors. Bone 1995, 17, 87s–91s. [Google Scholar] [CrossRef]
  24. Yoneda, T.; Hagino, H.; Sugimoto, T.; Ohta, H.; Takahashi, S.; Soen, S.; Taguchi, A.; Nagata, T.; Urade, M.; Shibahara, T.; et al. Antiresorptive agent-related osteonecrosis of the jaw: Position paper 2017 of the japanese allied committee on osteonecrosis of the jaw. J. Bone Miner. Metab. 2017, 35, 6–19. [Google Scholar] [CrossRef] [PubMed]
  25. Ganesan, K. Bisphosphonate, 2nd ed.; Roane, D., Ed.; Statpearls: Lakeland, FL, USA, 2018; NBK470248. [Google Scholar]
  26. Bernardi, S.; Di Girolamo, M.; Necozione, S.; Continenza, M.A.; Cutilli, T. Antiresorptive drug-related osteonecrosis of the jaws, literature review and 5 years of experience. Musculoskelet. Surg. 2018. [Google Scholar] [CrossRef] [PubMed]
  27. Minkin, C.; Marinho, V.C. Role of the osteoclast at the bone-implant interface. Adv. Dent. Res. 1999, 13, 49–56. [Google Scholar] [CrossRef] [PubMed]
  28. Kim, M.H.; Lee, S.Y.; Heo, S.J.; Kim, S.K.; Kim, M.J.; Koak, J.Y. Osteoclastic response on titanium surfaces in modified simulated body fluid. Int. J. Oral Maxillofac. Implant. 2017, 32, 337–343. [Google Scholar] [CrossRef] [PubMed]
  29. Zeng, X.Z.; He, L.G.; Wang, S.; Wang, K.; Zhang, Y.Y.; Tao, L.; Li, X.J.; Liu, S.W. Aconine inhibits rankl-induced osteoclast differentiation in raw264.7 cells by suppressing nf-kappab and nfatc1 activation and dc-stamp expression. Acta Pharmacol. Sin. 2016, 37, 255–263. [Google Scholar] [CrossRef] [PubMed]
  30. Branemark, R.; Branemark, P.I.; Rydevik, B.; Myers, R.R. Osseointegration in skeletal reconstruction and rehabilitation: A review. J. Rehabil. Res. Dev. 2001, 38, 175–181. [Google Scholar] [PubMed]
  31. Rajpura, A.; Kendoff, D.; Board, T.N. The current state of bearing surfaces in total hip replacement. Bone Joint J. 2014, 96, 147–156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Denry, I.; Kelly, J.R. State of the art of zirconia for dental applications. Dent. Mater. 2008, 24, 299–307. [Google Scholar] [CrossRef] [PubMed]
  33. Sennerby, L.; Dasmah, A.; Larsson, B.; Iverhed, M. Bone tissue responses to surface-modified zirconia implants: A histomorphometric and removal torque study in the rabbit. Clin. Implant. Dent. Relat. Res. 2005, 7, S13–S20. [Google Scholar] [CrossRef] [PubMed]
  34. Hashim, D.; Cionca, N.; Courvoisier, D.S.; Mombelli, A. A systematic review of the clinical survival of zirconia implants. Clin. Oral Investig. 2016, 20, 1403–1417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Haynes, D.R.; Crotti, T.N.; Zreiqat, H. Regulation of osteoclast activity in peri-implant tissues. Biomaterials 2004, 25, 4877–4885. [Google Scholar] [CrossRef] [PubMed]
  36. Nishimura, K.; Shindo, S.; Movila, A.; Kayal, R.; Abdullah, A.; Savitri, I.J.; Ikeda, A.; Yamaguchi, T.; Howait, M.; Al-Dharrab, A.; et al. Trap-positive osteoclast precursors mediate ros/no-dependent bactericidal activity via tlr4. Free Radic. Biol. Med. 2016, 97, 330–341. [Google Scholar] [CrossRef] [PubMed]
  37. Hefti, T.; Frischherz, M.; Spencer, N.D.; Hall, H.; Schlottig, F. A comparison of osteoclast resorption pits on bone with titanium and zirconia surfaces. Biomaterials 2010, 31, 7321–7331. [Google Scholar] [CrossRef] [PubMed]
  38. Lossdorfer, S.; Schwartz, Z.; Wang, L.; Lohmann, C.H.; Turner, J.D.; Wieland, M.; Cochran, D.L.; Boyan, B.D. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. J. Biomed. Mater. Res. A 2004, 70, 361–369. [Google Scholar] [CrossRef] [PubMed]
  39. Halai, M.; Ker, A.; Meek, R.D.; Nadeem, D.; Sjostrom, T.; Su, B.; McNamara, L.E.; Dalby, M.J.; Young, P.S. Scanning electron microscopical observation of an osteoblast/osteoclast co-culture on micropatterned orthopaedic ceramics. J. Tissue Eng. 2014, 5, 2041731414552114. [Google Scholar] [CrossRef] [PubMed]
  40. Burstone, M.S. Histochemical demonstration of acid phosphatase activity in osteoclasts. J. Histochem. Cytochem. 1959, 7, 39–41. [Google Scholar] [CrossRef] [PubMed]
  41. Minkin, C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 1982, 34, 285–290. [Google Scholar] [CrossRef] [PubMed]
  42. Bang, S.M.; Moon, H.J.; Kwon, Y.D.; Yoo, J.Y.; Pae, A.; Kwon, I.K. Osteoblastic and osteoclastic differentiation on sla and hydrophilic modified sla titanium surfaces. Clin. Oral Implants Res. 2014, 25, 831–837. [Google Scholar] [CrossRef] [PubMed]
  43. Matsuo, K.; Galson, D.L.; Zhao, C.; Peng, L.; Laplace, C.; Wang, K.Z.; Bachler, M.A.; Amano, H.; Aburatani, H.; Ishikawa, H.; et al. Nuclear factor of activated t-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-fos. J. Biol. Chem. 2004, 279, 26475–26480. [Google Scholar] [CrossRef] [PubMed]
  44. Rowe, A.R.; Mansfeldt, C.B.; Heavner, G.L.; Richardson, R.E. Relating mrna and protein biomarker levels in a dehalococcoides and methanospirillum-containing community. Appl. Microbiol. Biotechnol. 2015, 99, 2313–2327. [Google Scholar] [CrossRef] [PubMed]
  45. Parmigiani-Izquierdo, J.M.; Cabana-Munoz, M.E.; Merino, J.J.; Sanchez-Perez, A. Zirconia implants and peek restorations for the replacement of upper molars. Int. J. Implant Dent. 2017, 3, 5. [Google Scholar] [CrossRef] [PubMed]
  46. Stumpel, L.J.; Haechler, W. The metal-zirconia implant fixed hybrid full-arch prosthesis: An alternative technique for fabrication. Compend. Contin. Educ. Dent. 2018, 39, 176–181. [Google Scholar] [PubMed]
Figure 1. Scanning electron microscope (SEM) images of the surfaces of Ti disk and zirconia disk; Control group = Ti disk; each row, left to right, original magnification (a) 1000×; (b) 5000×; (c) 20,000×. Test group = zirconia disk: (d) 1000×; (e) 5000×; (f) 20,000×.
Figure 1. Scanning electron microscope (SEM) images of the surfaces of Ti disk and zirconia disk; Control group = Ti disk; each row, left to right, original magnification (a) 1000×; (b) 5000×; (c) 20,000×. Test group = zirconia disk: (d) 1000×; (e) 5000×; (f) 20,000×.
Materials 12 00732 g001
Figure 2. 3D images of the surface microstructures with dimensional range of 50 µm as captured by confocal laser scanning microscopy (CLSM). (a) Control group = Ti disk; (b) Test group = zirconia disk.
Figure 2. 3D images of the surface microstructures with dimensional range of 50 µm as captured by confocal laser scanning microscopy (CLSM). (a) Control group = Ti disk; (b) Test group = zirconia disk.
Materials 12 00732 g002
Figure 3. Surface roughness-related parameters obtained by CLSM. (a) Ra (surface roughness); (b) Sa (arithmetic mean height deviation from a mean plane.
Figure 3. Surface roughness-related parameters obtained by CLSM. (a) Ra (surface roughness); (b) Sa (arithmetic mean height deviation from a mean plane.
Materials 12 00732 g003
Figure 4. Energy dispersive X-ray spectroscopy (EDS) patterns of the zirconia disk compared with the Ti disk. (a) Control group = Ti disk; (b) Test group = zirconia disk.
Figure 4. Energy dispersive X-ray spectroscopy (EDS) patterns of the zirconia disk compared with the Ti disk. (a) Control group = Ti disk; (b) Test group = zirconia disk.
Materials 12 00732 g004
Figure 5. Scanning electron microscopy images showing differentiated osteoclasts that were seeded on the Ti disk and the zirconia disk. (a) Cells seeded on a Ti disk, original magnification 200×; (b) original magnification 2000×; (c) Cells seeded on a zirconia disk, original magnification 200×; (d) original magnification 2000×.
Figure 5. Scanning electron microscopy images showing differentiated osteoclasts that were seeded on the Ti disk and the zirconia disk. (a) Cells seeded on a Ti disk, original magnification 200×; (b) original magnification 2000×; (c) Cells seeded on a zirconia disk, original magnification 200×; (d) original magnification 2000×.
Materials 12 00732 g005
Figure 6. Tartrate-resistant acid phosphatase (TRACP) activity of osteoclasts on Ti disks and zirconia disks. (a) Absorbance values after three days of cell culturing; there was no significant difference between the two groups; (b) Absorbance value after five days of cell culture; there was no significant difference between the two groups. (p > 0.05; the bar represents mean ± SD).
Figure 6. Tartrate-resistant acid phosphatase (TRACP) activity of osteoclasts on Ti disks and zirconia disks. (a) Absorbance values after three days of cell culturing; there was no significant difference between the two groups; (b) Absorbance value after five days of cell culture; there was no significant difference between the two groups. (p > 0.05; the bar represents mean ± SD).
Materials 12 00732 g006
Figure 7. The mRNA levels of osteoclastogenic transcriptional factors on Ti disks and zirconia disks were measured by real time reverse transcriptase-polymerase chain reaction (RT-PCR). (a) c-Fos mRNA levels at day two and four; (b) NFATc1 mRNA levels at day two and four. (* p < 0.05; the bar represents mean ± SD; all values are normalized to mRNA levels on Ti at day two).
Figure 7. The mRNA levels of osteoclastogenic transcriptional factors on Ti disks and zirconia disks were measured by real time reverse transcriptase-polymerase chain reaction (RT-PCR). (a) c-Fos mRNA levels at day two and four; (b) NFATc1 mRNA levels at day two and four. (* p < 0.05; the bar represents mean ± SD; all values are normalized to mRNA levels on Ti at day two).
Materials 12 00732 g007
Figure 8. Protein levels of osteoclastogenic transcription factors in cells grown on Ti disks and zirconia disks were assayed by western blot analysis. Protein levels c-Fos on zirconia disks were thicker than Ti disks at day two. Protein levels of NFATc1 were not different across Ti and zirconia disks at any time point.
Figure 8. Protein levels of osteoclastogenic transcription factors in cells grown on Ti disks and zirconia disks were assayed by western blot analysis. Protein levels c-Fos on zirconia disks were thicker than Ti disks at day two. Protein levels of NFATc1 were not different across Ti and zirconia disks at any time point.
Materials 12 00732 g008
Table 1. Genes and primer sequences used in reverse transcriptase-polymerase chain reaction (RT-PCR).
Table 1. Genes and primer sequences used in reverse transcriptase-polymerase chain reaction (RT-PCR).
Gene NamePrimer Sequences (F = forward; R = reverse)
GAPDH(F) 5′-TGCACCACCAACTGCTTAGC-3′,
(R) 5′-GGCATGGACTGTGGTCATGAG-3′;
c-Fos(F) 5′-CTGGTGCAGCCCACTCTGGTC-3′,
(R) 5′-CTTTCAGCAGATTGGCAATCTC-3′;
NFATc1(F) 5′-CGGCTGCCTTCCGTCTCATAG-3′,
(R) 5′-CGGCTGCCTTCCGTCTCATAG-3′.

Share and Cite

MDPI and ACS Style

Ganbold, B.; Kim, S.-K.; Heo, S.-J.; Koak, J.-Y.; Lee, Z.H.; Cho, J. Osteoclastogenesis Behavior of Zirconia for Dental Implant. Materials 2019, 12, 732. https://doi.org/10.3390/ma12050732

AMA Style

Ganbold B, Kim S-K, Heo S-J, Koak J-Y, Lee ZH, Cho J. Osteoclastogenesis Behavior of Zirconia for Dental Implant. Materials. 2019; 12(5):732. https://doi.org/10.3390/ma12050732

Chicago/Turabian Style

Ganbold, Boldbayar, Seong-Kyun Kim, Seong-Joo Heo, Jai-Young Koak, Zang Hee Lee, and Jaejin Cho. 2019. "Osteoclastogenesis Behavior of Zirconia for Dental Implant" Materials 12, no. 5: 732. https://doi.org/10.3390/ma12050732

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop